
2nd Luncheon with the Experts — Carcinoid and Neuroendocrine Tumor Patients Are Invited!!
The Big Apple Noids support group has announced the second Luncheon with the Experts on Sunday, March 3, 2013. This program, initiated and sponsored by the Big Apple Noids in collaboration with the Carcinoid Cancer Foundation, brings together carcinoid…
READ MORE
Unique Lung Carcinoid Conference to Feature European and American Physicians
When Dr. Dan Granberg, a leading carcinoid and neuroendocrine cancer specialist at Uppsala University in Sweden, joins Dr. Eric H. Liu, Director of the Neuroendocrine Tumor Center at Vanderbilt University Medical Center in Nashville, Tennessee, …
READ MORE
Carcinoid Cancer Foundation Releases “Lung Carcinoid” Video
According to the latest research, 28% of all carcinoids occur in the lung. Bronchial or lung carcinoids account for approximately 1% to 2% of all lung cancers in adults. “Lung Carcinoid” is the newest video in the Carcinoid Cancer Foundation’s 2012-2103…
READ MORE
8 Easy Steps to Sign Up for Carcinoid Cancer and Neuroendocrine Tumor Google Alerts
Do you want to get the latest news about carcinoid and other neuroendocrine tumors delivered directly to your email address? Are you interested in stories about carcinoid/NET survivors, research, clinical trials, blogs, physicians, or organizations? …
READ MORE
2nd World Congress on Ga-68, Molecular Imaging & Targeted Radionuclide Therapy
Chandigarh, India will be the site of the 2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals), Molecular Imaging (PET/CT), Targeted Radionuclide Therapy and Dosimetry: On the Way to Personalized Medicine from February 28 through…
READ MORE
Luncheon with the Experts — Carcinoid and Neuroendocrine Tumor Patients Are Invited!!
The Big Apple Noids support group has initiated and is sponsoring, in collaboration with the Carcinoid Cancer Foundation, Luncheon with the Experts, a program which brings together carcinoid and neuroendocrine tumor (NET) patients with physicians…
READ MORE
Treating Neuroendocrine Tumors: New Patent Awarded
Herbert Chen, MD, and Muthusamy Kunnimalaiyaan, Ph.D., of the University of Wisconsin School of Medicine and Public Health in Madison, have received a patent (8,338,482) for a “Modulating Notch1 Signaling Pathway for Treating Neuroendocrine…
READ MORE
Happy New Year from the Carcinoid Cancer Foundation
As 2012 draws to a close, the Carcinoid Cancer Foundation would like to thank each of you for your support. This year has been especially exciting because of our work on the Worldwide NET Cancer Awareness Day Alliance, with Grace Goldstein, CCF’s Chief…
READ MORE
New Videos in Carcinoid Cancer Foundation 2012-2013 Series
Faces of Hope and Surgery and Treatment Options are the newest videos in the Carcinoid Cancer Foundation’s 2012-2013 series. Awareness and education are the first critical components in the fight against carcinoid and NET (neuroendocrine …
READ MORE
10 Highlights of the Year 2012 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2012, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community. Here are 10 of the year’s important stories:
1) NET Cancer Day, November …
READ MORE